Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis

中止 分裂情感障碍 帕利哌酮 抗精神病药 精神科 安慰剂 精神分裂症(面向对象编程) 危险系数 医学 心理学 静坐不能 内科学 精神病 置信区间 病理 替代医学
作者
Lasse Brandt,Kerstin Ritter,Johannes Schneider‐Thoma,Spyridon Siafis,Christiane Montag,Hakan Ayrilmaz,Felix Bermpohl,Alkomiet Hasan,Andreas Heinz,Stefan Leucht,Stefan Gutwinski,Heiner Stuke
出处
期刊:The Lancet Psychiatry [Elsevier BV]
卷期号:10 (3): 184-196 被引量:13
标识
DOI:10.1016/s2215-0366(23)00008-1
摘要

Predicting relapse for individuals with psychotic disorders is not well established, especially after discontinuation of antipsychotic treatment. We aimed to identify general prognostic factors of relapse for all participants (irrespective of treatment continuation or discontinuation) and specific predictors of relapse for treatment discontinuation, using machine learning.For this individual participant data analysis, we searched the Yale University Open Data Access Project's database for placebo-controlled, randomised antipsychotic discontinuation trials with participants with schizophrenia or schizoaffective disorder (aged ≥18 years). We included studies in which participants were treated with any antipsychotic study drug and randomly assigned to continue the same antipsychotic drug or to discontinue it and receive placebo. We assessed 36 prespecified baseline variables at randomisation to predict time to relapse, using univariate and multivariate proportional hazard regression models (including multivariate treatment group by variable interactions) with machine learning to categorise the variables as general prognostic factors of relapse, specific predictors of relapse, or both.We identified 414 trials, of which five trials with 700 participants (304 [43%] women and 396 [57%] men) were eligible for the continuation group and 692 participants (292 [42%] women and 400 [58%] men) were eligible for the discontinuation group (median age 37 [IQR 28-47] years for continuation group and 38 [28-47] years for discontinuation group). Out of the 36 baseline variables, general prognostic factors of increased risk of relapse for all participants were drug-positive urine; paranoid, disorganised, and undifferentiated types of schizophrenia (lower risk for schizoaffective disorder); psychiatric and neurological adverse events; higher severity of akathisia (ie, difficulty or inability to sit still); antipsychotic discontinuation; lower social performance; younger age; lower glomerular filtration rate; benzodiazepine comedication (lower risk for anti-epileptic comedication). Out of the 36 baseline variables, predictors of increased risk specifically after antipsychotic discontinuation were increased prolactin concentration, higher number of hospitalisations, and smoking. Both prognostic factors and predictors with increased risk after discontinuation were oral antipsychotic treatment (lower risk for long-acting injectables), higher last dosage of the antipsychotic study drug, shorter duration of antipsychotic treatment, and higher score on the Clinical Global Impression (CGI) severity scale The predictive performance (concordance index) for participants who were not used to train the model was 0·707 (chance level is 0·5).Routinely available general prognostic factors of psychotic relapse and predictors specific for treatment discontinuation could be used to support personalised treatment. Abrupt discontinuation of higher dosages of oral antipsychotics, especially for individuals with recurring hospitalisations, higher scores on the CGI severity scale, and increased prolactin concentrations, should be avoided to reduce the risk of relapse.German Research Foundation and Berlin Institute of Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
leemark发布了新的文献求助10
1秒前
1秒前
单薄的凡灵的应助被小牙医采纳,获得10
1秒前
欢喜书雁完成签到,获得积分10
2秒前
2秒前
CipherSage的应助被hxzcell采纳,获得10
2秒前
核桃发布了新的文献求助10
2秒前
小库里2025发布了新的文献求助10
3秒前
liuqingyun完成签到,获得积分10
3秒前
3秒前
4秒前
4秒前
4秒前
hyy发布了新的文献求助10
6秒前
di发布了新的文献求助10
6秒前
星翼完成签到,获得积分10
6秒前
李RP发布了新的文献求助10
6秒前
7秒前
时淮靖的应助被shg采纳,获得10
7秒前
小二郎的应助被余杭村王小虎采纳,获得10
7秒前
细腻戒指发布了新的文献求助10
7秒前
可爱的函函的应助被oo采纳,获得30
7秒前
8秒前
Plateau发布了新的文献求助10
8秒前
8秒前
诸葛烤鸭发布了新的文献求助10
8秒前
YK完成签到,获得积分10
8秒前
8秒前
zxcv1发布了新的文献求助10
9秒前
1112233发布了新的文献求助10
9秒前
赘婿的应助被GZU老僵尸采纳,获得10
9秒前
10秒前
10秒前
10秒前
BAIBAI完成签到,获得积分10
10秒前
SciGPT的应助被凡123采纳,获得10
10秒前
shiqi发布了新的文献求助10
11秒前
小桃子发布了新的文献求助10
11秒前
脑洞疼的应助被小白采纳,获得10
12秒前
hao完成签到,获得积分20
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8156628
求助须知:如何正确求助?哪些是违规求助? 9552750
关于积分的说明 21711279
捐赠科研通 7745718
什么是DOI,文献DOI怎么找? 3426593
关于科研通互助平台的介绍 2551401
邀请新用户注册赠送积分活动 2470435